NCT05012228View on ClinicalTrials.gov

Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

December 31, 2024

Conditions

Renal Fibrosis, CKD

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER